United States · FDA National Drug Code directory

CEFPROZIL

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 68180-273_f2cfb43d-9704-49ca-8eae-97327e62044d
Product NDC: 68180-273
Form: POWDER, FOR SUSPENSION
Composition / generic term: cefprozil
Labeler: Lupin Pharmaceuticals, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20260504
Source listing expiry: 20271231

Source-listed ingredients

CEFPROZIL — 250 mg/5mL

These values do not establish equivalence or a dose recommendation.

Packages

50 mL in 1 BOTTLE (68180-273-01) · 68180-273-01
75 mL in 1 BOTTLE (68180-273-02) · 68180-273-02
100 mL in 1 BOTTLE (68180-273-03) · 68180-273-03

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →